These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38507608)

  • 21. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient education interventions for the management of inflammatory bowel disease.
    Gordon M; Sinopoulou V; Ibrahim U; Abdulshafea M; Bracewell K; Akobeng AK
    Cochrane Database Syst Rev; 2023 May; 5(5):CD013854. PubMed ID: 37172140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
    Loncharich MF; Anderson CW
    ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacy-based management for depression in adults.
    Brown JVE; Walton N; Meader N; Todd A; Webster LA; Steele R; Sampson SJ; Churchill R; McMillan D; Gilbody S; Ekers D
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD013299. PubMed ID: 31868236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of emergency department pharmacists on drug overuse and drug underuse in patients with an ADE-related hospitalisation: a controlled intervention study.
    Rahman RN; Nikolik B; de Ridder MAJ; Hoek AE; Janssen MJA; Schuit SCE; Karapinar-Çarkit F; van den Bemt PMLA
    BMC Health Serv Res; 2022 Nov; 22(1):1363. PubMed ID: 36397102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse drug reactions: a retrospective review of hospitalized patients at a state psychiatric hospital.
    Iuppa CA; Nelson LA; Elliott E; Sommi RW
    Hosp Pharm; 2013 Dec; 48(11):931-5. PubMed ID: 24474834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse Drug Reactions from Real-World Data in Inflammatory Bowel Disease Patients in the IBDREAM Registry.
    Giraud EL; Thomas PWA; van Lint JA; van Puijenbroek EP; Römkens TEH; West RL; Russel MGVM; Jansen JM; Jessurun NT; Hoentjen F;
    Drug Saf; 2021 May; 44(5):581-588. PubMed ID: 33538994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventing Adverse Drug Reactions After Hospital Discharge (PADR-AD): Protocol for a randomised-controlled trial in older people.
    Cousins J; Parameswaran Nair N; Curtain C; Bereznicki B; Wilson K; Adamczewski B; Barratt A; Webber L; Simpson T; McKenzie D; Connolly M; Bereznicki L
    Res Social Adm Pharm; 2022 Aug; 18(8):3284-3289. PubMed ID: 34593344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefits and Risks Associated With Continuation of Anti-Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease : A Nationwide Emulation Trial.
    Meyer A; Neumann A; Drouin J; Weill A; Carbonnel F; Dray-Spira R
    Ann Intern Med; 2022 Oct; 175(10):1374-1382. PubMed ID: 36162111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness of pharmacist- led discharge medication counselling in the emergency department (ExPLAIN): A pilot quasi-experimental study.
    Cabilan CJ; Boyde M; Currey E
    Patient Educ Couns; 2019 Jun; 102(6):1157-1163. PubMed ID: 30712945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacist-led medication review to identify medication-related problems in older people referred to an Aged Care Assessment Team: a randomized comparative study.
    Elliott RA; Martinac G; Campbell S; Thorn J; Woodward MC
    Drugs Aging; 2012 Jul; 29(7):593-605. PubMed ID: 22715865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial.
    Radley A; de Bruin M; Inglis SK; Donnan PT; Hapca A; Barclay ST; Fraser A; Dillon JF
    Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):809-818. PubMed ID: 32526210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland.
    Augustin M; Bock PR; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2005; 55(1):38-49. PubMed ID: 15727163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series.
    Larussa T; Basile A; Palleria C; Iannelli C; Vero A; Giubilei L; De Sarro C; Suraci E; Marasco R; Imeneo M; Russo E; Abenavoli L; De Sarro G; Luzza F
    Med Pharm Rep; 2021 Jul; 94(3):289-297. PubMed ID: 34430850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
    Korcegez EI; Sancar M; Demirkan K
    J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacist-Led Mobile Health Intervention and Transplant Medication Safety: A Randomized Controlled Clinical Trial.
    Gonzales HM; Fleming JN; Gebregziabher M; Posadas-Salas MA; Su Z; McGillicuddy JW; Taber DJ
    Clin J Am Soc Nephrol; 2021 May; 16(5):776-784. PubMed ID: 33931415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacist intervention to improve medication safety for hip fracture patients through secondary and primary care settings: a nonrandomised controlled trial.
    Henriksen BT; Krogseth M; Andersen RD; Davies MN; Nguyen CT; Mathiesen L; Andersson Y
    J Orthop Surg Res; 2023 Jun; 18(1):434. PubMed ID: 37312222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
    Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
    Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time series analysis of using the PDCA method combined with the Teach-back method to improve spontaneous reports of adverse drug reactions in a grade IIIA hospital in China.
    Li B; Jiang L; Liao L; Chen Y; Xu Z; Wu N; Chen H; Wu P; Liu T
    Eur J Clin Pharmacol; 2024 Mar; 80(3):383-393. PubMed ID: 38151504
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.